The Cigna Group (NYSE:CI) is one of the best inexpensive stocks to buy according to hedge funds. On August 29, Phothera announced that Cigna has updated its coverage policy for home phototherapy, ...

More than 66.7 million Americans now covered for safe, effective at-home treatment for psoriasis, eczema, and vitiligo This follows a similar recent coverage decision by Elevance Health/Anthem, which ...

Jaundice is one of the most common medical issues in newborns, affecting nearly 80% of full-term infants in their first days of life. The condition occurs when excess bilirubin, a yellow pigment ...

Adding twice-weekly narrowband UVB phototherapy to oral ritlecitinib may enhance response to treatment of nonsegmental vitiligo. Dual treatment was well-tolerated with no new safety signals in this ...

Background: Prurigo nodularis is a chronic pruritic dermatosis and narrowband-UVB (NB-UVB) phototherapy is considered an effective and safe treatment option in patients with multiple comorbidities.

A project at MIT has developed microparticles able to be implanted at a tumor site and deliver two types of therapeutic treatment. As reported in ACS Nano, the particles enable both chemotherapy and ...

For decades, people with psoriasis have been treated in clinics with narrowband ultraviolet B phototherapy, or light therapy, to reduce sores, scales, and inflammation. Now, new research from the ...

Please provide your email address to receive an email when new articles are posted on . 32.8% of patients using home-based phototherapy achieved clear or almost clear skin vs. 25.6% of office-based ...